scholarly article | Q13442814 |
P50 | author | Björn Lindkvist | Q47308691 |
P2093 | author name string | Björn Lindkvist | |
P2860 | cites work | Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test | Q24541364 |
Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum | Q28340685 | ||
Properties of different pancreatin preparations used in pancreatic exocrine insufficiency | Q30054022 | ||
Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency | Q30870593 | ||
Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis | Q33311111 | ||
Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial | Q33446564 | ||
A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery | Q33449829 | ||
On the site of absorption of fat from the human small intestine | Q34254510 | ||
The epidemiology of pancreatitis and pancreatic cancer | Q34341477 | ||
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis | Q34422620 | ||
A test of pancreatic function in man based on the analysis of duodenal contents after administration of secretin and pancreozymin | Q34477504 | ||
EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification | Q34604850 | ||
Cigarette smoking accelerates progression of alcoholic chronic pancreatitis | Q35597261 | ||
Human pancreatic exocrine response to nutrients in health and disease | Q35790597 | ||
Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency | Q36184845 | ||
13C mixed-triglyceride breath test: isotope selective non-dispersive infrared spectrometry in comparison with isotope ratio mass spectrometry in volunteers and patients with chronic pancreatitis | Q73229924 | ||
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test | Q74456840 | ||
Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis | Q74494123 | ||
The effect of gastric distension on duodenal aspirates in man | Q76404301 | ||
The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis | Q79989894 | ||
13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis | Q80185332 | ||
Rapid method for the determination of fat in feces | Q80275926 | ||
Magnetic resonance imaging and magnetic resonance cholangiopancreatography findings compared with fecal elastase 1 measurement for the diagnosis of chronic pancreatitis | Q80487509 | ||
Neurohumoral control of exocrine pancreatic secretion | Q81386435 | ||
Endoscopic ultrasonography of the pancreas as an indirect method to predict pancreatic exocrine insufficiency in patients with chronic pancreatitis | Q83194724 | ||
Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis | Q83462341 | ||
A modified ¹³C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency | Q84448313 | ||
Nutritional profile of asymptomatic alcoholic patients | Q84458265 | ||
On a refinement of the ¹³C-mixed TAG breath test | Q84512207 | ||
High Prevalence of Low-Trauma Fracture in Chronic Pancreatitis | Q84800544 | ||
Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis | Q84812665 | ||
A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis | Q86549444 | ||
Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study | Q36482162 | ||
MRI and S-MRCP findings in patients with suspected chronic pancreatitis: correlation with endoscopic pancreatic function testing (ePFT). | Q37699189 | ||
Pancreatic exocrine insufficiency: diagnosis and treatment. | Q37842755 | ||
Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? | Q37850103 | ||
The role of fecal elastase-1 in detecting exocrine pancreatic disease | Q37883016 | ||
The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). | Q38080329 | ||
Nutritional deficiencies in chronic pancreatitis | Q38711363 | ||
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules | Q39145826 | ||
Comparative Effects of Antacids, Cimetidine and Enteric Coating on the Therapeutic Response to Oral Enzymes in Severe Pancreatic Insufficiency | Q39166076 | ||
Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? | Q39289976 | ||
Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. | Q42855673 | ||
Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery. | Q42947552 | ||
Cigarette smoking is independently associated with chronic pancreatitis | Q43120518 | ||
Cortical and trabecular bone microarchitecture and turnover in alcohol-induced chronic pancreatitis: a histomorphometric study | Q43184262 | ||
Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. | Q43367920 | ||
The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis | Q43861006 | ||
Fat malabsorption screening in chronic pancreatitis | Q44963248 | ||
Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection | Q46209709 | ||
A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis | Q46738019 | ||
Biochemical vitamin E deficiency in chronic pancreatitis | Q46836160 | ||
A randomized crossover study of secretin-stimulated endoscopic and dreiling tube pancreatic function test methods in healthy subjects | Q46924815 | ||
Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study | Q47819758 | ||
Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey | Q47927633 | ||
Bone mineral density in patients with pancreatic insufficiency and steatorrhea. | Q50956114 | ||
Meal-stimulated secretin release in man: effect of acid and bile. | Q51656042 | ||
Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. | Q51665614 | ||
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? | Q52854508 | ||
Fat-soluble vitamin concentration in chronic alcohol-induced pancreatitis. Relationship with steatorrhea. | Q53700645 | ||
S3-Leitlinie Chronische Pankreatitis: Definition, Ätiologie, Diagnostik, konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheit | Q56968232 | ||
Italian consensus guidelines for chronic pancreatitis | Q57289932 | ||
Does Secretin-stimulated MRCP Predict Exocrine Pancreatic Insufficiency? | Q61908098 | ||
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function | Q61908173 | ||
Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis | Q68486986 | ||
Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic Insufficiency | Q69496537 | ||
Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects | Q69567819 | ||
Elastase 1 and chymotrypsin B in pancreatic juice and feces | Q69609958 | ||
Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder? | Q70171079 | ||
Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output | Q71354004 | ||
Lipoproteins and chronic pancreatitis | Q72242635 | ||
Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy | Q72400579 | ||
Diarrhoea and reversible enteropathy in Zollinger-Ellison syndrome | Q72494810 | ||
Effect of pancreatic ductal and parenchymal changes on exocrine function in chronic pancreatitis | Q72652083 | ||
The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis | Q72718212 | ||
P433 | issue | 42 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7258-7266 | |
P577 | publication date | 2013-11-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Diagnosis and treatment of pancreatic exocrine insufficiency. | |
P478 | volume | 19 |
Q58804235 | Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding |
Q40796229 | Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes. |
Q64089463 | Bruising as the first sign of exocrine pancreatic insufficiency in infancy |
Q38805333 | Causal Evaluation of Acute Recurrent and Chronic Pancreatitis in Children: Consensus From the INSPPIRE Group. |
Q26768526 | Chronic pancreatitis: A diagnostic dilemma |
Q55312999 | Chronic pancreatitis: review and update of etiology, risk factors, and management. |
Q58601993 | Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients |
Q49554058 | Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel |
Q98892456 | Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review |
Q24186170 | Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis |
Q93108152 | Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1 |
Q64239358 | Exocrine pancreatic function is preserved in systemic sclerosis |
Q37586255 | Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy |
Q48099475 | Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician |
Q45914147 | Less common etiologies of exocrine pancreatic insufficiency. |
Q39152875 | Pancreatic Exocrine Insufficiency in Pancreatic Cancer |
Q58754774 | Pancreatic Involvement in Inflammatory Bowel Disease: A Review |
Q49795312 | Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets |
Q47096424 | Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss. |
Q54971828 | Pancreatic function following post-endoscopic retrograde cholangiopancreatography pancreatitis: A controlled cohort study with long-term follow-up. |
Q39185556 | Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. |
Q42322542 | Practical guide to exocrine pancreatic insufficiency - Breaking the myths |
Q26866465 | The Pancreas: Causes for Malabsorption |
Q42883689 | Understanding and treatment of chronic pancreatitis |
Q93001640 | Which factors determine exocrine pancreatic dysfunction in diabetes mellitus? |
Search more.